3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
2.0192 0.5994 -0.6781 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2870 -0.6952 1.2534 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2474 1.6523 0.0653 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4744 0.2953 0.0197 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2533 -0.3160 -0.2732 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7126 0.7210 -0.4014 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0714 1.9194 -0.1879 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6550 -0.4305 0.2133 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2061 -1.7203 -0.3786 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2459 2.6631 0.3393 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5838 -1.8221 0.1038 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3792 -2.4592 -0.1876 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7552 -0.1654 0.2544 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1997 -0.2417 -0.1423 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4477 2.9338 -0.1959 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5961 0.0593 0.4402 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7218 -2.2345 -0.6119 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6616 2.4767 1.3328 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7840 3.6533 0.3115 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.0236 2.5961 -0.4258 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.4830 -2.4156 0.2479 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3490 -3.5425 -0.2694 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2876 -0.7196 -1.1210 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7466 -0.8414 0.5906 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6290 0.7628 -0.1638 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 13 1 0 0 0 0
2 13 2 0 0 0 0
3 4 1 0 0 0 0
3 7 1 0 0 0 0
3 10 1 0 0 0 0
4 5 1 0 0 0 0
4 8 2 0 0 0 0
5 6 1 0 0 0 0
5 9 2 0 0 0 0
6 7 2 0 0 0 0
7 15 1 0 0 0 0
8 11 1 0 0 0 0
8 16 1 0 0 0 0
9 12 1 0 0 0 0
9 17 1 0 0 0 0
10 18 1 0 0 0 0
10 19 1 0 0 0 0
10 20 1 0 0 0 0
11 12 2 0 0 0 0
11 21 1 0 0 0 0
12 22 1 0 0 0 0
13 14 1 0 0 0 0
14 23 1 0 0 0 0
14 24 1 0 0 0 0
14 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(1-methylindol-3-yl) acetate
4.2 InChl
InChI=1S/C11H11NO2/c1-8(13)14-11-7-12(2)10-6-4-3-5-9(10)11/h3-7H,1-2H3
4.3 InChlKey
QSVQMVRTWNDRDT-UHFFFAOYSA-N
4.4 Canonical SMILES
CC(=O)OC1=CN(C2=CC=CC=C21)C
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病